SG3 Management, LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 163 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
SG3 Management, LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$300,000
-71.7%
100,000
-65.7%
0.01%
-75.0%
Q3 2021$1,060,000
+28.6%
291,956
+54.0%
0.03%
+6.7%
Q2 2021$824,000
-45.2%
189,600
-56.9%
0.03%
-18.9%
Q1 2021$1,503,000
+133.4%
439,900
+139.1%
0.04%
+208.3%
Q4 2020$644,000
+257.8%
184,000
+145.3%
0.01%
+100.0%
Q3 2020$180,00075,0000.01%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,847,087$4,119,0003.26%
Sio Capital Management, LLC 1,333,696$2,974,0001.52%
Boxer Capital, LLC 700,000$1,561,0001.38%
Palo Alto Investors LP 5,386,534$12,012,0000.91%
ACUTA CAPITAL PARTNERS, LLC 747,748$1,667,0000.80%
SENZAR ASSET MANAGEMENT, LLC 1,443,003$3,217,897,0000.70%
Ghost Tree Capital, LLC 800,000$1,784,0000.52%
NEA Management Company, LLC 3,243,150$7,232,0000.38%
Rhenman & Partners Asset Management AB 850,000$1,896,0000.34%
Rock Springs Capital Management LP 1,750,000$3,903,0000.29%
View complete list of RIGEL PHARMACEUTICALS INC shareholders